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SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article. Six GSTP1 polymorphisms were examined to assess for a potential effect on CMM risk (Table 1) . GSTP1 rs4891 was in strong linkage disequilibrium with rs1695 (r 2 =0.92, Table S1 ). Although previous studies have suggested the involvement of rs1695 in CMM risk (also apparent when stratified by study, MC1R variant genotypes designated using WT, r and R allele classification and risk of CMM (Table 2 ). These effects were not modified by GSTP1 rs1695 genotype (A/A, A/G, G/G) in the stratified analysis (overall P=0.79). This result was also confirmed when restricted to MC1R Arg151Cys genotype (WT/WT, WT/R, R/R), the MC1R allele of highest penetrance for CMM and red hair colour (Table S3) . Moreover, examination of each MC1R allele individually did not show any interaction with GSTP1 rs1695 genotype and CMM risk (Table S4 ).
The reported association of rs1695 and light hair colour 6 was not seen in our analysis. However, the rs1138272 GSTP1 Ala114Val
SNP showed weak association with darker hair colour in the BTNS and German case samples. This was not replicated in the analysis of the larger BLTS, Genes and Blood Clotting study (GABC) or UK 1958 birth cohort studies. Neither of these SNPs was associated with skin colour. 
| CONCLUSIONS
The role of GSTP1 polymorphism in CMM has been examined in several candidate studies with some positive reports of association. 1, 2 In the most recent meta-analysis, an association of rs1695 with CMM risk was detected (P=.033 in a dominant model). 1 However, this conclusion is not supported in larger GWAS analyses such as reported in Law et al. 8 who studied 16 000 CMM cases and 26 000 controls. In this study, we similarly saw an association in our German case subsample that did not replicate in the larger German KORA controls or our full sample. Our conclusion is that GSTP1 polymorphisms do not have any large effect on risk of CMM. The effects of rare variants of GSTP1 on CMM remain to be clarified in larger studies.
We also examined the hypothesis that GSTP1 may interact with other CMM risk loci as recently reported. 6 This study is considerably larger than the group studied by Ibarrola-Villava et al. and should have good statistical power to replicate any true association. There was no modification effect found in the combination of GSTP1 Ile105Val with MC1R RHC-variant alleles. Finally, we also excluded the effects of GSTP1 on phenotypic risk factors for CMM, including hair and skin colour. WT, r and R alleles were as defined in Beaumont et al. 
T A B L E 2 Interaction between MC1R RHC-variant and GSTP1 rs1695 genotypes

SUPPORTING INFORMATION
Additional Supporting Information may be found online in the supporting information tab for this article. Table S1 . Linkage disequilibrium between GSTP1 rs1695 and rs4891 MTAP has a tumor suppressor activity and epigenetic silencing has been described in melanoma cell lines. In the present study, we show that melanoma risk alleles correlate with a MTAP allele-specific hyper-methylation and downregulation of gene expression.
| BACKGROUND
Empirical and computational data support the notion that a considerable proportion of SNPs associated with human diseases are expression quantitative trait loci (eQTLs).
[1] Genetic variants in promoter or enhancer regions may influence transcript levels by modulating the binding of transcription factors to DNA, or by affecting the methylation status of the promoter. [2] Allele-specific gene expression and promoter methylation have been found to be relatively common in human genome. [3, 4] Meta-analysis of melanoma genetic association studies corroborates, among others, the association of a region at 9p21.3, where the methylthioadenosine phosphorylase (MTAP) gene resides. [5] MTAP is an anti-oncogene, and its reduction in gene expression exerts a tumorpromoting effect, including induction of invasiveness, enhanced cell proliferation and resistance against cytokines. [6] Evidence exists that variants linked to the associated intergenic and intronic regions of MTAP locus are eQTLs. [7] Epigenetic silencing by promoter hypermethylation has been described as a mechanism of MTAP inactivation in melanoma cell lines, and it has been associated with tumor progression.
[8]
| QUESTIONS ADDRESSED
The identification of the causative polymorphisms responsible for the observed associations represents an important challenge, and suggestions
